Shares in Sequenom dropped 11.3 percent for the five-day trading period ended Tuesday. It marked the third week in a row the firm’s shares have declined, and followed last week’s 9.2 percent drop. There had been no recent news regarding the company — though it did report after Tuesday that it had received commitments from institutional investors to buy a total of 6,666,666 shares of Sequenom for $3 per share.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.